Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	275.71	374.04	240.94	409.25	191.98	-
Short-Term Investments	65.59	79.94	130.94	-	-	-
Cash & Short-Term Investments	341.31	453.98	371.88	409.25	191.98	-
Cash Growth	-33.02%	22.08%	-9.13%	113.18%	-	-
Other Receivables	-	0.94	0.92	0.2	0.15	-
Receivables	-	0.94	0.92	0.2	0.15	-
Prepaid Expenses	6.09	4.27	1.62	1.2	0.78	-
Restricted Cash	1.21	-	0.05	0.13	0.13	-
Other Current Assets	-	19.09	13.48	4.84	0.81	-
Total Current Assets	348.61	478.28	387.96	415.6	193.84	-
Property, Plant & Equipment	3.93	6.86	10.64	4.04	3.92	-
Long-Term Investments	-	9.85	23.51	-	-	-
Long-Term Deferred Charges	-	-	2.9	1.83	-	-
Other Long-Term Assets	-	1.21	1.23	7.82	0.18	-
Total Assets	352.54	496.2	426.23	429.3	197.95	-
Accounts Payable	6.11	0.34	7.15	1.64	2.4	-
Accrued Expenses	22.76	21.26	11.54	19.1	5.6	0.02
Current Portion of Leases	2.75	3.38	3.37	1.06	0.76	-
Other Current Liabilities	0.13	0.14	1.64	1.49	0.61	-
Total Current Liabilities	31.74	25.11	23.7	23.28	9.37	0.02
Long-Term Leases	-	1.85	5.07	1	1.28	-
Other Long-Term Liabilities	0.06	0.16	0.63	0.39	-	-
Total Liabilities	31.8	27.12	29.4	24.66	10.65	0.02
Common Stock	0.02	0.02	0	0.01	0.01	-
Additional Paid-In Capital	1,209	1,173	21.43	11.37	4.9	-
Retained Earnings	-888.4	-703.43	-467.51	-336.61	-99.29	-0.02
Comprehensive Income & Other	0.11	-0.08	-0.77	-	-	-
Total Common Equity	320.74	469.08	-446.85	-325.22	-94.38	-0.02
Shareholders' Equity	320.74	469.08	396.84	404.64	187.3	-0.02
Total Liabilities & Equity	352.54	496.2	426.23	429.3	197.95	-
Total Debt	2.75	5.23	8.44	2.05	2.05	-
Net Cash (Debt)	338.56	458.6	386.95	407.2	189.93	-
Net Cash Growth	-34.05%	18.51%	-4.97%	114.39%	-	-
Net Cash Per Share	2.15	7.05	14.22	18.60	14.61	-
Filing Date Shares Outstanding	161.56	158.89	32.61	31.98	30.61	-
Total Common Shares Outstanding	160.48	158.83	32.61	31.98	30.61	-
Working Capital	316.87	453.17	364.26	392.33	184.47	-0.02
Book Value Per Share	2.00	2.95	-13.70	-10.17	-3.08	-
Tangible Book Value	320.74	469.08	-446.85	-325.22	-94.38	-0.02
Tangible Book Value Per Share	2.00	2.95	-13.70	-10.17	-3.08	-
Machinery	-	3.18	2.94	2.3	1.83	-
Construction In Progress	-	0.04	0.51	0.22	-	-
Leasehold Improvements	-	-	0.02	0.26	0.21	-

Source: S&P Capital IQ. Standard template. Financial Sources.